View in EDS HTML Full Text PDF Full Text

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

Saved in:
Bibliographic Details
Title: The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
Authors: van den Bent MJ; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, The Netherlands., French PJ; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Brat D; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Tonn JC; Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Germany., Touat M; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, Paris Brain Institute, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France., Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, USA., Young RJ; Neuroradiology Service, Department of Radiology, Memorial Sloan Kettering Cancer, New York, New York, USA., Pallud J; Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-Brain, Université Paris Cité, Paris, France.; Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne, Paris, France., von Deimling A; Department of Neuropathology, University Hospital Medicine and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Sahm F; Department of Neuropathology, University Hospital Medicine and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Figarella Branger D; DFB Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France., Huang RY; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Weller M; Department of Neurology & Brain Tumor Center, University Hospital Zurich & University of Zurich, Zurich, Switzerland., Mellinghoff IK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Cloughsey TF; Department of Neurology, TC David Geffen School of Medicine at UCLA, Los Angeles, USA., Huse JT; Departments of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aldape K; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Reifenberger G; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf, Germany., Youssef G; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Karschnia P; German Cancer Consortium (DKTK), Partner Site Munich, Germany.; Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany., Noushmehr H; Department of Neurosurgery, Henry Ford Hospital+Michigan State University, Detroit, Michigan, USA., Peters KB; Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA., Ducray F; Inserm U1052, CNRS UMR5286, Université Claude Bernard Lyon, Lyon, France.; Hospices Civils de Lyon, Service de neuro-oncologie, LabEx Dev2CAN, Centre de Recherche en Cancérologie de Lyon, France., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Source: Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1805-1822.
Publication Type: Journal Article; Review
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38912846
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+den+Bent+MJ%22">van den Bent MJ</searchLink>; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22French+PJ%22">French PJ</searchLink>; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Brat+D%22">Brat D</searchLink>; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Tonn+JC%22">Tonn JC</searchLink>; Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Touat+M%22">Touat M</searchLink>; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, Paris Brain Institute, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ellingson+BM%22">Ellingson BM</searchLink>; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Young+RJ%22">Young RJ</searchLink>; Neuroradiology Service, Department of Radiology, Memorial Sloan Kettering Cancer, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Pallud+J%22">Pallud J</searchLink>; Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-Brain, Université Paris Cité, Paris, France.; Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne, Paris, France.<br /><searchLink fieldCode="AU" term="%22von+Deimling+A%22">von Deimling A</searchLink>; Department of Neuropathology, University Hospital Medicine and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Sahm+F%22">Sahm F</searchLink>; Department of Neuropathology, University Hospital Medicine and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Figarella+Branger+D%22">Figarella Branger D</searchLink>; DFB Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Huang+RY%22">Huang RY</searchLink>; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Weller+M%22">Weller M</searchLink>; Department of Neurology & Brain Tumor Center, University Hospital Zurich & University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mellinghoff+IK%22">Mellinghoff IK</searchLink>; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Cloughsey+TF%22">Cloughsey TF</searchLink>; Department of Neurology, TC David Geffen School of Medicine at UCLA, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Huse+JT%22">Huse JT</searchLink>; Departments of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Aldape+K%22">Aldape K</searchLink>; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Reifenberger+G%22">Reifenberger G</searchLink>; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Youssef+G%22">Youssef G</searchLink>; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Karschnia+P%22">Karschnia P</searchLink>; German Cancer Consortium (DKTK), Partner Site Munich, Germany.; Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Noushmehr+H%22">Noushmehr H</searchLink>; Department of Neurosurgery, Henry Ford Hospital+Michigan State University, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Peters+KB%22">Peters KB</searchLink>; Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Ducray+F%22">Ducray F</searchLink>; Inserm U1052, CNRS UMR5286, Université Claude Bernard Lyon, Lyon, France.; Hospices Civils de Lyon, Service de neuro-oncologie, LabEx Dev2CAN, Centre de Recherche en Cancérologie de Lyon, France.<br /><searchLink fieldCode="AU" term="%22Preusser+M%22">Preusser M</searchLink>; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Wen+PY%22">Wen PY</searchLink>; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1805-1822.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38912846
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/neuonc/noae107
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1805
    Titles:
      – TitleFull: The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van den Bent MJ
      – PersonEntity:
          Name:
            NameFull: French PJ
      – PersonEntity:
          Name:
            NameFull: Brat D
      – PersonEntity:
          Name:
            NameFull: Tonn JC
      – PersonEntity:
          Name:
            NameFull: Touat M
      – PersonEntity:
          Name:
            NameFull: Ellingson BM
      – PersonEntity:
          Name:
            NameFull: Young RJ
      – PersonEntity:
          Name:
            NameFull: Pallud J
      – PersonEntity:
          Name:
            NameFull: von Deimling A
      – PersonEntity:
          Name:
            NameFull: Sahm F
      – PersonEntity:
          Name:
            NameFull: Figarella Branger D
      – PersonEntity:
          Name:
            NameFull: Huang RY
      – PersonEntity:
          Name:
            NameFull: Weller M
      – PersonEntity:
          Name:
            NameFull: Mellinghoff IK
      – PersonEntity:
          Name:
            NameFull: Cloughsey TF
      – PersonEntity:
          Name:
            NameFull: Huse JT
      – PersonEntity:
          Name:
            NameFull: Aldape K
      – PersonEntity:
          Name:
            NameFull: Reifenberger G
      – PersonEntity:
          Name:
            NameFull: Youssef G
      – PersonEntity:
          Name:
            NameFull: Karschnia P
      – PersonEntity:
          Name:
            NameFull: Noushmehr H
      – PersonEntity:
          Name:
            NameFull: Peters KB
      – PersonEntity:
          Name:
            NameFull: Ducray F
      – PersonEntity:
          Name:
            NameFull: Preusser M
      – PersonEntity:
          Name:
            NameFull: Wen PY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 10
              Text: 2024 Oct 03
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1523-5866
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Neuro-oncology
              Type: main
ResultId 1